BI: Immunotherapy, Vaccines and Virotherapy, Center for (CIVV)

Fingerprint Dive into the research topics where BI: Immunotherapy, Vaccines and Virotherapy, Center for (CIVV) is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer

    Villa, N. Y., Franco, L. S. & McFadden, G., Jan 1 2020, Methods in Molecular Biology. Humana Press Inc., p. 95-110 16 p. (Methods in Molecular Biology; vol. 2058).

    Research output: Chapter in Book/Report/Conference proceedingChapter

  • Genome characterization of cetaceanpox virus from a managed Indo-Pacific bottlenose dolphin (Tursiops aduncus)

    Rodrigues, T. C. S., Subramaniam, K., Varsani, A., McFadden, G., Schaefer, A. M., Bossart, G. D., Romero, C. H. & Waltzek, T. B., Mar 2020, In : Virus research. 278, 197861.

    Research output: Contribution to journalArticle

  • High Level Production of Monoclonal Antibodies Using an Optimized Plant Expression System

    Diamos, A. G., Hunter, J. G. L., Pardhe, M. D., Rosenthal, S. H., Sun, H., Foster, B. C., DiPalma, M. P., Chen, Q. & Mason, H. S., Jan 17 2020, In : Frontiers in Bioengineering and Biotechnology. 7, 472.

    Research output: Contribution to journalArticle

    Open Access
  • Projects